Yubo International Biotech remains in a pre-revenue development stage with minimal commercial activity, though it reduced its operating and net losses year-over-year while facing a severe liquidity crisis that raises substantial doubt about its ability to continue as a going concern.
—
Market Cap
—
Revenue
—
Net Income
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.